The Osteoarthritis Research Society International Congress 2024 will take place in Vienna, Austria, from April 18 to 21.

Our Chief Medical Officer, Professor Francis Berenbaum, is scheduled to deliver an oral presentation on Friday, April 19, 2024. His presentation is titled IN-MOTION: "Pioneering a Phase 2b Clinical Trial Tailored for Inflamed Phenotypes in Knee Osteoarthritis with Intraarticular Liraglutide."

Coralie Meurot, our preclinical research scientist, will present her poster, "Intra-articular Administration of Liraglutide Mitigates Synovial Tissue Alteration and Cartilage Degradation in Preclinical Osteoarthritis Models during the poster presentations session.

‍

‍

‍